• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AWC
Click for more information
0.00% $1.45

ALUMINA LIMITED - Charts / Financials

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Alumina Limited is an Australia-based company, which invests in bauxite mining and... Alumina Limited is an Australia-based company, which invests in bauxite mining and alumina refining through Alcoa World Alumina and Chemicals (AWAC), its joint venture with Alcoa Corporation (Alcoa). The principal activities of the Company relate to its 40% interest in the series of operating entities forming AWAC. AWAC has interests in bauxite mining, alumina refining and aluminum smelting. The Company is the 40% partner in the AWAC joint venture with a portfolio of assets in Australia, Brazil, Spain, Saudi Arabia, and Guinea, including global bauxite mines and alumina refineries. AWAC also has a 55% interest in the Portland aluminum smelter in Victoria, Australia. Its subsidiaries include Alumina Employee Share Plan Pty Ltd, Alumina Finance Pty Ltd., Alumina Holdings (USA) Inc., Alumina International Holdings Pty. Ltd., Alumina Brazil Holdings Pty Ltd, Alumina Limited Do Brasil SA, Alumina (U.S.A.) Inc., Butia Participacoes SA, and Westminer Acquisition (U.K.) Limited.More

refresh Created with Sketch. REFRESH
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Mr. Michael Peter Ferraro Chief Executive Officer, Managing Director, Executive Director
Ms. Galina Kraeva Chief Financial Officer
Ms. Katherine Kloeden General Counsel, Company Secretary
Mr. W. Peter Day Non-Executive Independent Chairman of the Board
Mr. Chen Zeng Non-Executive Director
Mr. John Andrew Bevan Non-Executive Independent Director
Mr. Alistair Field Independent Non-Executive Director
Ms. Deborah M. O'toole Non-Executive Independent Director

Data source: Refinitiv

Top Stories

Firebird achieves preliminary approvals for its Jinshi plant design

Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.